News

18.06.2018
Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A

Lachen, Switzerland 18 June 2018: Octapharma announced today that the European Medicines Agency...

28.05.2018
Octapharma share promising preclinical data for SubQ-8, a novel subcutaneous recombinant FVIII, at WFH 2018

Lachen, Switzerland 28 May 2018: Octapharma announced today that pre-clinical data for SubQ-8 were p...

Since its establishment over 30 years ago, Octapharma has grown into a truly global company providing life enhancing therapies to patients in over 100 countries. To find your local Octapharma office, access our global locations map

“As a world-wide provider of human proteins as treatments in immunotherapy, haematology, and intensive care and emergency medicine, Octapharma is constantly investing in the renovation and modernisation of our plants.„

Wolfgang Marguerre
Chairman of the Board